Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharma Responds To Sandy’s Wrath With Delays

This article was originally published in The Pink Sheet Daily

Executive Summary

As the East Coast braces for the impact of Hurricane Sandy, companies choose the safety of their employees over keeping financial releases on schedule.

You may also be interested in...

FDA Faced With A Judgment Call On Hydrocodone Upscheduling

Commenters in favor of and opposed to new restrictions on combination hydrocodone products make strong cases, but without much new data.

Pharma Only Slightly Winded By Hurricane Sandy

While most of the East Coast of the U.S. continues to struggle with the aftereffects of Hurricane Sandy, pharmaceutical industry operations are back to normal and the companies are doing what they can to help out.

AbbVie Issues Record Debt To Support Independence

The future Abbott spin-off tapped the bond market for financing just days after Hurricane Sandy brought trading to a halt and hours before the U.S. faced a leadership decision.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts